GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight

NCT04779697 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: GLP-1 analogue - semaglutide
OTHER: Placebo

Sponsor

Yale University

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)